Search results
Results from the WOW.Com Content Network
(Reuters) -The U.S. House of Representatives passed a bill on Monday that aims to restrict business with China's WuXi AppTec, BGI and several other biotech companies on national security grounds ...
WuXi AppTec's services range from conducting research and development to making pharmaceutical raw materials and manufacturing drugs. Its customers include large pharmaceutical companies and small ...
WuXi PharmaTech was founded in December 2000 in Shanghai by organic chemist Ge Li. [1] [2]The company opened chemistry facilities in Tianjin in 2007. In 2008, WuXi PharmaTech acquired AppTec Laboratory Services Inc., a US-based company founded in 2001 with expertise in medical-device and biologics testing and with facilities in St. Paul, MN; Philadelphia, PA; and Atlanta, GA.
The bill has spurred deep concern among investors, driving a sell-off in the shares of WuXi AppTec when news of its introduction first reached Chinese markets last month. US Senate bill targeting ...
[6] [9] [11] [12] [13] Other notable companies it has invested in include WuXi AppTec, [6] Amyris, [14] Angiotech Pharmaceuticals [15] and Precision BioSciences. [ 16 ] Vivo headquartered in Palo Alto, California with additional offices in Beijing , Hong Kong , Shanghai and Taipei .
In 2016, WuXi AppTec expanded its presence in the United States by opening a new center of excellence in San Diego, California. [10] This facility was designed to enhance WuXi's capabilities in small molecule screening, discovery biology, and process research and development, while also offering Phase I Good manufacturing practice (GMP
(Reuters) -A new version of a congressional bill that would restrict U.S. business with certain Chinese biotechnology companies including WuXi AppTec and BGI would give U.S. companies until 2032 ...
WuXi Biologics is a global Contract Research Development and Manufacturing Organization (CRDMO) that provides open-access, integrated technology platforms for biologics drug development. WuXi Biologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery, development and good ...